跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Bevespi Aerosphere - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Bevespi Aerosphere
Approved
STANDARD
Bevespi Aerosphere
AstraZeneca Dunkerque Production
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
a33d48ba4398ecfa
Company
AstraZeneca Dunkerque Production
Type
Standard
Approval Details
Approval Id
a33d48ba4398ecfa
Drug Approval Philippines Name
Bevespi Aerosphere
Product Name
Bevespi Aerosphere
Registration Number
DR-XY47549
Brand Name
Bevespi Aerosphere
Generic Name
Glycopyrronium (as bromide) + Formoterol fumarate dihydrate
Dosage Form
Pressurized Suspension for Inhalation
Dosage Strength
7.2 mcg/5 mcg per actuation
Manufacturer
AstraZeneca Dunkerque Production
Importer
AstraZeneca Pharmaceuticals (Phils.), Inc.
Company Detail Path
/organization/astrazeneca-dunkerque-production
Issuance Date
19 November 2021
Expiry Date
19 November 2026
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
a33d48ba4398ecfa
Type
Standard
Back to Philippines FDA Approvals